首页> 外文会议>Microfluidics, bioMEMS, and medical microsystems XVI >Behavior of HepG2 liver cancer cells using microfluidic-microscopy: A preliminary study
【24h】

Behavior of HepG2 liver cancer cells using microfluidic-microscopy: A preliminary study

机译:微流控显微镜观察HepG2肝癌细胞的行为:初步研究

获取原文
获取原文并翻译 | 示例

摘要

Hepatocellular carcinoma is one of the most common types of liver cancer causing death all over the world. Although early-stage liver cancer can sometimes be treated with partial hepatectomy, liver transplantation, ablation, and embolization, sorafenib treatment is the only approved systemic therapy for advanced HCC. The aim of this research is to develop tools and methods to understand the individuality of hepatocellular carcinoma. Microfluidic cell-culture platform has been developed to observe behavior of single-cells; fluorescence microscopy has been implemented to investigate phenotypic changes of cells. Our preliminary data proved high-level heterogeneity of hepatocellular carcinoma while verifying limited growth of liver cancer cell lines on the silicon wafer.
机译:肝细胞癌是引起死亡的最常见的肝癌类型之一。尽管早期肝癌有时可以通过部分肝切除术,肝移植,消融和栓塞治疗,但索拉非尼治疗是唯一被批准用于晚期HCC的全身疗法。这项研究的目的是开发工具和方法,以了解肝细胞癌的个性。已经开发出微流体细胞培养平台来观察单细胞的行为。荧光显微镜已被用来研究细胞的表型变化。我们的初步数据证明了肝细胞癌的高水平异质性,同时证实了硅片上肝癌细胞系的有限生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号